Hello, Guest!

MS Money Moves

We empower biotech investors with research solutions so that you can save time and be profitable

Join us with a free trial

How It Works

  1. Step 1: Join now with a quarterly or monthly subscription. You can make sure we’re a good fit for you with a free trial and cancel anytime

Step 2: Check your email for our nightly updates with 4-5 researched tickers for the next day. This includes; price targets, the bull thesis, risk estimates, and time frame estimates

Step 3: Check your phone during trading hours for our SMS alerts. We send 1-2 per day with; our price target, risk and time frame estimate, and the support we are monitoring

Play the below video for a description of our service

Step 4: Login to your account to view our time saving research reports, podcasts and more on our favorite stocks

Step 5: Coming soon! Exclusive chatroom and courses will soon be available to our community

Step 6: Reach out if you have any questions. We have a best in class customer service standing by to answer any questions that arise

Recent Wins

Core Performance

  • Win %
  • Average % gain
  • Average time frame : 6 months+
  • Total stocks per year

*Coming soon

Email Performance

  • Win %
  • Average % gain
  • Average time frame : 0-1 month
  • Total stocks per year | 760+

*Coming soon

  • Win Ratio | 80%
  • Average Max Gain | 22%
  • Average Time Frame | 0-4 Weeks
  • Total stocks per year | 280+

What Our Subscribers Say About US


The MS executive team has extensive experience between them and complimentary skill sets gained through actively investing in the biotech industry. Over the years they have developed a strategy and fine-tuned research methods, yielding returns that have proven to outpace the market and many analysts. 

Zion Miller

CEO & Co Founder

Sultan Beardsley

COO & Co Founder

Chris Stang


Michael Lipari


Travis Kellerman



Updated Every Night!

This is our nightly email which includes the following for our community;

  1. > Market updates, what happened in the previous session, what’s forecasted to happen tomorrow
  2.  > 4-5 researched tickers with bullet points on their story and how we might plan to trade them. Includes a price target
  3. > Click below to see last nights email
BioCryst Pharmaceuticals (Nasdaq: BCRX): Embarrassment of Riches

May 27, 2020 by Sultan Beardsley

Over the years BCRX has successfully commercialized multiple products including Peramivir injection for influenza and Mundesine for Peripheral T-cell lymphoma (PTCL). While Peramivir and Mundasine are valuable in their own respects, it is Berotralstat (now called Orladeyo), BCX9930, Galidesivir, and BCX9250 that are central to our discussion of BCRX’s embarrassment of riches. Ultimately, in our view, BCRX is one of the most misunderstood biotech stocks of 2020 and on the cusp of a significant transformation and growth.

SMS Alerts

Guidelines For SMS Alerts *We send on average 1-2 per day

  • >We like to use 1-5% of our account value for day & or swing trades
  • >Price targets are estimates. Do not be deterred from selling before it is hit if you are in the green (have made a profit) on the position. Sometimes stocks run past the price we send a sell alert. 
  • >Consider stop losses even if not mentioned. Generally, stop losses are best set a percent below the first major support level (ask if you are unsure what this is).
  • >Cut losses quick if the trend changes
  • >Do not trade when feeling emotional or pressured to make back losses


MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.

The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.